Beruflich Dokumente
Kultur Dokumente
et al
M E D I C A L CHANNEL
Original Article FREQUENCY OF HEPATOTOXICITY DURING ANTI-TUBERCULOUS TREATMENT AT MEDICAL UNIT OF LUMHS SINDH
1. 2. 3. MUMTAZ ALI SHAIKH DUR-E-YAKTA DARGAHI SHAIKH ABSTRACT Objective: To evaluates the frequency of development of hepatotoxicity in patients with tuberculosis on antituberculous treatment presenting in department of Medicine Liaquat University of Medical and Health Sciences Jamshoro. Methodology: This prospective, descriptive study was carried out on five hundred diagnosed patients with tuberculosis, during March 2008 to March 2011. In this study tuberculous patients were included who were consecutively admitted in department of medicine or attended medical out-patient department of Liaquat University of Medical and Health Sciences (LUMHS) Jamshoro. The patients, who developed hepatitis, while they were on antituberculous therapy, were evaluated. The criteria for diagnosing hepatitis were clinical manifestations of acute hepatitis along with rise in serum liver enzymes by three times from baseline and excluding other causes of rise in enzymes. In all patients who presented to us with acute hepatitis while on antituberculous therapy, sera were analysed for, liver function tests and the presence of markers of acute viral hepatitis A, B, C and E. The patients who developed viral hepatitis were excluded from study. Patients with tuberculosis who received the full course of antituberculous therapy without developing hepatitis formed the control group; they were compared with patients who developed hepatitis due to antituberculous therapy. Statistics: The results are expressed as the mean SD. For the comparison of quantitative data, the Students t test was applied using SPSS 16. Values of p < 0.05 were regarded as significant. Results: The age of these patients ranged from 15 to 80 years, the mean age being 41.8 17.6 years. The male-to-female ratio of these patients was 300(60%) males to 200(40%) females. Pulmonary tuberculosis was the most common definite indications for starting ATT Table-1. 55 patients (11%) out of 500 developed ATT-induced hepatitis. Five (1%) patients with antituberculous treatment induced hepatitis died Table 2. The mean age of patients with fatal complications in our study was 50.13.5 years. The values of various liver function tests during follow-up are shown in Table 3. Conclusion: It was concluded that ATT-induced hepatitis is not an uncommon problem in field of Medicine. Key Words: Antituberculous treatment; hepatotoxicity. INTRODUCTION Tuberculosis is a common problem in subcontinent and worldwide, especially after the recent increase in incidence of acquired immunodeficiency syndrome. According to the World Health Organization there were an estimated 9.27 million new cases of tuberculosis worldwide in 20071. Pakistan ranks eighth on the list of 22 high-burden tuberculosis countries with an estimated 743 new cases of tuberculosis annually. Multi drug-resistant tuberculosis (MDR-TB) and XDR-TB (eXtensively drug-resistant tuberculosis) are the greatest health hazards for those infected with HIV/AIDS2. Abdominal tuberculosis commonly affects the intestinal tract. Isolated hepatobiliary or pancreatic tuberculosis 20
1.
2.
3.
Associate Professor Department of Medicine Liaquat University of Medical and Health Sciences Jamshoro, Sind Pakistan Assistant Professor Department of Ophthalmology GMMMC SUKKER, SMBBU Larkana Senior Anaesthetist SMBBU, Larkana
Corresponding Address: Dr MUMTAZ ALI SHAIKH 205 A, Al-Raheem Heights Unit NO. 6, Latifabad Hyderabad E-mail: ali_mumtazali@yahoo.com Tel: 03003019364
www.medicalchannel.pk
TABLE 1 PRIMARY DIAGNOSIS OF CASES OF TUBERCULOSIS FOR WHICH ATT WAS STARTED N500 Primary Diagnosis Total No of Patients n 500 (100%) 292(58.4%) 90(18%) 30(06%) 15(03%) 05(01%) 03(0.8%) 65(13%) No of Patients with hepatotoxicity n55 (11%) 36 09 04 01 00 00 05 No of Patients without hepatotoxicity n 445 (89%) 259 81 26 14 05 03 60
21
www.medicalchannel.pk
TABLE 3 THE VALUES OF VARIOUS LIVER FUNCTION TESTS RECORDED DURING THE SERIAL FOLLOW-UP OF PATIENTS WITH ATT INDUCED HEPATOTOXICITY. MEAN (SD) AS WELL AS THE RANGE IS SHOWN N 55 PARAMETERS LFT prior to ATD Mean SD Serum bilirubin (mg/dl) AST (U/L) ALT (U/L ALP (U/L) INR 0.408 0.196 36.97.9 25.1 4.87 68.126.3 1.07 0.205 Range 0.22-0.9 23-38.8 15-30.8 35.5-150 0.8-1.38 LFT after liver injury Mean SD 9.09 8.18 585526 546660 188.32.1 2.34 1.39 Range 2.46-35 130-2100 141-2850 170-260 0.7-5.8 P value 0.0009 0.0017 0.0049 0.0001 0.0001
RESULTS In this study five hundred tuberculous patients were included. The age of these patients ranged from 15 to 80 years, the mean age being 41.8 17.6 years. The male-to-female ratio of these patients was 300(60%) males to 200(40%) females. Pulmonary tuberculosis was the most common definite indications for starting ATT Table 1. The largest group among the study patients was one where ATT was given empirically. The clinical presentation of ATT-induced hepatitis was same as that of acute viral hepatitis. 55 patients (11%) out of 500 patients developed ATT-induced hepatitis and experienced symptoms suggestive of prodrome associated with acute viral hepatitis (anorexia, nausea, vomiting and upper-abdominal discomfort) with jaundice. Forty (8%) out of 55 patients with ATT-induced hepatitis had an uncomplicated course. The clinical and biochemical resolution of hepatotoxicity was observed within 6 weeks of stopping ATT. Fifteen (3%) patients developed serious complications from ATT-induced hepatitis. Ten (2%) patients developed hepatic encephalopathy. 5 (1%) patients were subsequently found to have underlying chronic liver disease while remaining 5 (1%) patients were classified as fulminant hepatic failure. Five (1%) patients with antituberculous treatment induced hepatitis died Table 2. The mean age of patients with fatal complications in our study was 50.13.5 years. The values of various liver function tests during follow-up are shown in Table 3. Liver function tests are significantly deranged in patients with ATT induced hepatitis as evident from p value less than 0.05. DISCUSSION It has been recognized that despite approximately one third of the worlds population being infected with Mycobacterium tuberculosis, less than 10% of infected individuals are potentially threatened to
develop pulmonary tuberculosis during their lifetime10. The frequency of hepatotoxicity among patients on ATT is 11% in our study, which is similar to that reported in other studies [5%,10%,12%]. In one study the incidence of jaundice was 8.2% which is higher than previously reported studies and those who developed jaundice (72.7%) were above 35 years; therefore, it was recommended that patients who are more than 35 years of age and receiving ATT should be closely watched for evidence of drug induced hepatitis11. Our data with 55 patients with ATT-induced hepatotoxicity shows that this adverse drug reaction is common and is potentially fatal. In our experience, nearly one fourth developed serious complications, such as fulminant hepatic failure, with 5 patients (1%) ending fatally Table 2. In a study done on tuberculous patients jaundice was the presenting symptom in 44 (61%) patients; prodromal symptoms were present in 28 (39%). Serious complications developed in 12 (16.6%) patients12. Rifampicin, Pyrazinamide, and Isoniazid are known to cause liver injury; they cause hepatotoxicity and pancreatitis, which can lead to bile duct obstruction13. In literature, there is a wide disparity in the reported incidence of ATT-induced hepatitis ranging from 2 to 39%. In our study the frequency of hepatotoxicity among patients on ATT is 11%. The incidence has been reported to be higher in developing countries and factors such as acute or chronic liver disease, indiscriminate use of drugs, malnutrition and more advanced tuberculosis have been implicated14. The reported mortality from ATT-induced hepatitis after the development of jaundice varies from 4-12%15. In our study five (1%) patients with antituberculous induced hepatitis died which is less in comparison to other studies possibly due to early detection. Why only some patients who receive ATT develop hepatitis is not clear. Some studies have reported that the risk of ATT induced hepatitis increases with advancing age, the 22
www.medicalchannel.pk
8.
9. 10. 11. 12. 13. 14. 15. 16. 17. 18. 19.
23. 24.
WORK DISTRIBUTION IN STUDY 1. DR MUMTAZ ALI SHAIKH Introduction RESULTS Case collection Methods Statistics 2. DR DUR-E-YAKTA References Abstract Conclusion 3. DR DARGAHI SHAIKH Discussion References
23
www.medicalchannel.pk
Copyright of Medical Channel is the property of Medical Channel and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.